Does VERTEPORFIN Cause Off label use? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Off label use have been filed in association with VERTEPORFIN (Visudyne). This represents 17.1% of all adverse event reports for VERTEPORFIN.
129
Reports of Off label use with VERTEPORFIN
17.1%
of all VERTEPORFIN reports
1
Deaths
1
Hospitalizations
How Dangerous Is Off label use From VERTEPORFIN?
Of the 129 reports, 1 (0.8%) resulted in death, 1 (0.8%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VERTEPORFIN. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does VERTEPORFIN Cause?
Visual acuity reduced (173)
Polypoidal choroidal vasculopathy (128)
Disease progression (115)
Age-related macular degeneration (90)
Retinal haemorrhage (70)
Product use in unapproved indication (57)
Choroidal neovascularisation (47)
Retinal detachment (42)
Subretinal fluid (42)
Detachment of retinal pigment epithelium (36)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which VERTEPORFIN Alternatives Have Lower Off label use Risk?
VERTEPORFIN vs VESICARE
VERTEPORFIN vs VFEND
VERTEPORFIN vs VIAGRA
VERTEPORFIN vs VIBEGRON
VERTEPORFIN vs VICODIN